Abstract
Skin advanced glycation end products (AGEs) may better correlate with diabetes control, duration and complications than serum AGEs, as they reflect long-term tissue accumulation. We evaluated whether, in individuals with type 1 diabetes (T1D): 1). skin AGEs correlate with serum AGEs; 2). AGEs correlate with HbA1c and diabetes duration; 3). AGEs differ in those with microvascular complications from those without.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
